IP
Innate Pharma
🇺🇸XNAS.IPHAUnited StatesHealthcare
$1.85USDdown -0.15 (-7.5%)ClosedEnd of day12:15 AM
Price$1.85-0.15 (-7.5%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45781K2042
- CUSIP
- 45781K204
Company
- Employees
- 164
- Headquarters
- Marseille, United States
- CEO
- Mr. Jonathan E. Dickinson B.Sc., M.B.A.
Market
- Shares outstanding
- 111.7M
- Market cap
- $173.72M
Highlights
- Market cap
- $173.72M
- EPS LTM
- -€0.57
- P/E LTM
- -1.86
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €714K
- Net income
- -€52.1M
- Gross margin
- -2,773.95%
- Free cash flow
- -€48.35M
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.